MMSI

SEC source: 0000901534-25-000007 · form4-11212025_031155.xml · nonDerivative · entry 4

Lampropoulos Fred P. · CIK 0000901534 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,054,955

F3 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.01 to $86.3499, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0000901534-25-000005 · form4-11202025_091108.xml · nonDerivative · entry 4

Lampropoulos Fred P. · CIK 0000901534 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,074,955

F3 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.03 to $86.44, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001429832-25-000010 · form4a-10072025_101032.xml · nonDerivative · entry 1

Aronson Martha Goldberg · CIK 0001429832 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,594

F1 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001429832-25-000006 · form4-10072025_041036.xml · nonDerivative · entry 1

Aronson Martha Goldberg · CIK 0001429832 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,594

F1 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001415889-25-023580 · form4-09032025_090916.xml · derivative · entry 8

Lampropoulos Fred P. · CIK 0000901534 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.

F2 · ownership.nature: Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.

SEC source: 0001415889-25-023580 · form4-09032025_090916.xml · derivative · entry 7

Lampropoulos Fred P. · CIK 0000901534 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 159,151 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.

SEC source: 0001415889-25-023580 · form4-09032025_090916.xml · nonDerivative · entry 6

Lampropoulos Fred P. · CIK 0000901534 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 8,280.258

F4 · shares: The Reporting Person's spouse surrendered 1,454 shares of common stock to the Issuer for payroll taxes and payment of the option price. No shares were sold in the open market.

SEC source: 0001415889-25-023580 · form4-09032025_090916.xml · nonDerivative · entry 5

Lampropoulos Fred P. · CIK 0000901534 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 9,734.258

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · ownership.nature: Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.

SEC source: 0001415889-25-023580 · form4-09032025_090916.xml · nonDerivative · entry 4

Lampropoulos Fred P. · CIK 0000901534 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,079,955

F3 · shares: The Reporting Person surrendered 124,824 shares of common stock to the Issuer for payroll taxes and payment of the option price. No shares were sold in the open market.

SEC source: 0001415889-25-023580 · form4-09032025_090916.xml · nonDerivative · entry 3

Lampropoulos Fred P. · CIK 0000901534 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,204,779

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-25-022869 · form4-08252025_040845.xml · derivative · entry 3

Ward Lynne N. · CIK 0001786127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,000 shares

Expires 2026-08-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 08/28/2020.

SEC source: 0001415889-25-022869 · form4-08252025_040845.xml · nonDerivative · entry 2

Ward Lynne N. · CIK 0001786127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,809

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.49 to $88.77, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-25-022869 · form4-08252025_040845.xml · nonDerivative · entry 1

Ward Lynne N. · CIK 0001786127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,809

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-25-021473 · form4-08122025_040818.xml · derivative · entry 3

Ward Lynne N. · CIK 0001786127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 5,433 shares

Expires 2026-08-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 08/28/2020.

SEC source: 0001415889-25-021473 · form4-08122025_040818.xml · nonDerivative · entry 2

Ward Lynne N. · CIK 0001786127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,809

SEC source: 0001415889-25-021473 · form4-08122025_040818.xml · nonDerivative · entry 1

Ward Lynne N. · CIK 0001786127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,242

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-25-017578 · form4-06172025_090607.xml · derivative · entry 6

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,070

Underlying: Common Stock · 14,570 shares

Expires 2029-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.

SEC source: 0001415889-25-017578 · form4-06172025_090607.xml · derivative · entry 5

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,681 shares

Expires 2028-03-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.

SEC source: 0001415889-25-017578 · form4-06172025_090607.xml · nonDerivative · entry 4

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,201

F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.75 to $93.76, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-25-017578 · form4-06172025_090607.xml · nonDerivative · entry 3

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,382

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-25-017578 · form4-06172025_090607.xml · nonDerivative · entry 2

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,882

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-25-017043 · form4-06122025_100602.xml · nonDerivative · entry 4

Lampropoulos Fred P. · CIK 0000901534 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,045,628

SEC source: 0001415889-25-016204 · form4-06092025_060630.xml · nonDerivative · entry 4

Lampropoulos Fred P. · CIK 0000901534 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,046,028

F3 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.10 to $95.32 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-25-015455 · form4-06032025_090612.xml · nonDerivative · entry 2

Voigt Michel J. · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,724

SEC source: 0001415889-25-015452 · form4-06032025_090648.xml · nonDerivative · entry 2

McDonnell Michael R. · CIK 0001121897 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,395

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025.

SEC source: 0001415889-25-015452 · form4-06032025_090648.xml · nonDerivative · entry 1

McDonnell Michael R. · CIK 0001121897 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,145

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025.

SEC source: 0001415889-25-015450 · form4-06032025_090642.xml · nonDerivative · entry 2

Floyd David · CIK 0001564203 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · David K. Floyd Living Trust

Disclosed balance after: 4,880

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025

F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.87 to $94.46, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-25-015447 · form4-06032025_090640.xml · nonDerivative · entry 4

Lampropoulos Fred P. · CIK 0000901534 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,056,028

F3 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.01 to $95.23, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-25-014805 · form4-05292025_050510.xml · nonDerivative · entry 4

LAMPROPOULOS FRED P · CIK 0000901534 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,066,028

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.32 to $96.99, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-25-013726 · form4-05192025_100531.xml · derivative · entry 5

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2026-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.

SEC source: 0001415889-25-013726 · form4-05192025_100531.xml · derivative · entry 4

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,750 shares

Expires 2026-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.

SEC source: 0001415889-25-013726 · form4-05192025_100531.xml · nonDerivative · entry 3

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,543

F2 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

F3 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.16 to $97.16, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-25-013726 · form4-05192025_100531.xml · nonDerivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,793

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

SEC source: 0001415889-25-013726 · form4-05192025_100531.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,543

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-25-013724 · form4-05192025_100519.xml · nonDerivative · entry 1

Gunderson Thomas James · CIK 0001708144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,034

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-25-013721 · form4-05192025_100520.xml · nonDerivative · entry 1

Ward Lynne · CIK 0001786127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,809

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-25-013718 · form4-05192025_100525.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,895

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-25-013715 · form4-05192025_100528.xml · nonDerivative · entry 1

Kaiser Laura S. · CIK 0001726511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,895

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-25-013709 · form4-05192025_100517.xml · nonDerivative · entry 3

Floyd David · CIK 0001564203 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,033

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-25-013706 · form4-05192025_100515.xml · nonDerivative · entry 3

Floyd David · CIK 0001564203 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,033

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-25-013702 · form4-05192025_100533.xml · nonDerivative · entry 1

Evans Stephen C. · CIK 0001844301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,809

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-25-013700 · form4-05192025_100529.xml · nonDerivative · entry 1

Carpenter Lonny J · CIK 0001451534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,367

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-25-013698 · form4-05192025_100505.xml · nonDerivative · entry 1

Perez Silvia · CIK 0002024006 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,583

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-25-009677 · form4-04022025_080442.xml · derivative · entry 3

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 10,000 shares

Expires 2026-04-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2024.

F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 04/25/2020.

SEC source: 0001415889-25-009677 · form4-04022025_080442.xml · nonDerivative · entry 2

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,369

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2024.

F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.63 to $105.36, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-25-009677 · form4-04022025_080442.xml · nonDerivative · entry 1

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,369

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2024.

SEC source: 0001415889-25-008053 · form4-03142025_030342.xml · nonDerivative · entry 1

Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,245

SEC source: 0001415889-25-007270 · form4-03062025_100312.xml · derivative · entry 4

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,361 shares

Expires 2027-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing 02/26/2021.

SEC source: 0001415889-25-007270 · form4-03062025_100312.xml · nonDerivative · entry 3

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,201

F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.00 to $103.695, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-25-007270 · form4-03062025_100312.xml · nonDerivative · entry 2

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,562

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.